Abstract
We have used an unusual if not unique method of transfusion for the prospective, previously untransfused recipients of living related (LR) or cadaveric (CAD) first renal grafts. A single unit of third-party, HLA-defined blood is administered in three aliquots to these patients before grafting. The technique is based on the hypothesis that it is the repeated administration of mismatched HLA-DR in a 'booster' fashion that is responsible for maximizing graft survival. This unique method of pretransplant transfusion is safe, effective, and conserved blood. It compares favorably with other transfusion protocols and appears to augment the results in Cs-treated patients. It will not sensitize recipients to their related kidney donors and eliminates the need to treat these recipients with immunosuppressive agents during the transfusion period. It has the potential of minimizing the sensitization profile of prospective CAD kidney recipients to only a few selected mismatched major histocompatibility antigens.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 289-291 |
| Number of pages | 3 |
| Journal | Transplantation Proceedings |
| Volume | 20 |
| Issue number | 1 SUPPL. 1 |
| State | Published - 1988 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Surgery
- Transplantation
Cite this
An alternative, effective pretransplant transfusion method : Small-aliquot, repeated transfusions from the same third-party, HLA-defined blood donor. / Burrows, L.; Schanzer, H.; Miller, C.; Feingold, Robert E.; Fotino, M.
In: Transplantation Proceedings, Vol. 20, No. 1 SUPPL. 1, 1988, p. 289-291.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - An alternative, effective pretransplant transfusion method
T2 - Small-aliquot, repeated transfusions from the same third-party, HLA-defined blood donor
AU - Burrows, L.
AU - Schanzer, H.
AU - Miller, C.
AU - Feingold, Robert E.
AU - Fotino, M.
PY - 1988
Y1 - 1988
N2 - We have used an unusual if not unique method of transfusion for the prospective, previously untransfused recipients of living related (LR) or cadaveric (CAD) first renal grafts. A single unit of third-party, HLA-defined blood is administered in three aliquots to these patients before grafting. The technique is based on the hypothesis that it is the repeated administration of mismatched HLA-DR in a 'booster' fashion that is responsible for maximizing graft survival. This unique method of pretransplant transfusion is safe, effective, and conserved blood. It compares favorably with other transfusion protocols and appears to augment the results in Cs-treated patients. It will not sensitize recipients to their related kidney donors and eliminates the need to treat these recipients with immunosuppressive agents during the transfusion period. It has the potential of minimizing the sensitization profile of prospective CAD kidney recipients to only a few selected mismatched major histocompatibility antigens.
AB - We have used an unusual if not unique method of transfusion for the prospective, previously untransfused recipients of living related (LR) or cadaveric (CAD) first renal grafts. A single unit of third-party, HLA-defined blood is administered in three aliquots to these patients before grafting. The technique is based on the hypothesis that it is the repeated administration of mismatched HLA-DR in a 'booster' fashion that is responsible for maximizing graft survival. This unique method of pretransplant transfusion is safe, effective, and conserved blood. It compares favorably with other transfusion protocols and appears to augment the results in Cs-treated patients. It will not sensitize recipients to their related kidney donors and eliminates the need to treat these recipients with immunosuppressive agents during the transfusion period. It has the potential of minimizing the sensitization profile of prospective CAD kidney recipients to only a few selected mismatched major histocompatibility antigens.
UR - http://www.scopus.com/inward/record.url?scp=0023945266&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023945266&partnerID=8YFLogxK
M3 - Article
VL - 20
SP - 289
EP - 291
JO - Transplantation Proceedings
JF - Transplantation Proceedings
SN - 0041-1345
IS - 1 SUPPL. 1
ER -